blah blah blah!!
Anything, anything to divert from the reality that this ANN is a WATERSHED MOMENT for MSB
the NY analysts have got it right, nothing you can do alters this and that our product is effective in countering pain in identified groups. this has colossal implications for opiod dependency
meanwhile you're desperately struggling for relevance and trying to engage someone in a wrestling match about limited old therapies like steroids
pfft!
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-591
-
- There are more pages in this discussion • 513 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |